Xu Li
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy (NCT06078839) | Xu Li | 2023-10-01 |
Track Xu Li automatically
Every clearance here is in the API, with alerts when new ones post.